Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03182335 · ClinicalTrials.gov registry record
Vasopressor SAT Study
A clinical trial of Critical Illness and Delirium, sponsored by University of Chicago.
- Active
- Registry status
- 800
- Enrollment target
- 1
- Study location
NCT03182335: Active study of Critical Illness and Delirium, sponsored by University of Chicago.
NCT03182335 is a study of Critical Illness and Delirium that is active but no longer recruiting, run by University of Chicago. The registered enrollment target is 800 participants, below the 3,130-participant average among 91 other Critical Illness trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03182335, a study of Critical Illness and Delirium, is active but no longer recruiting, sponsored by University of Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 1
- Study location
Study Summary
To assess the impact of daily awakening from sedation on the amount of vasoactive medication required in the ICU. The hypothesis of this proposal is that the amount of vasoactive drug required to maintain an adequate mean arterial blood pressure will be reduced during a daily awakening from sedation.
Primary Outcome
mcg/kg/min baseline dose and nadir dose
Conditions Studied
Interventions
- OTHER sedation awakening trial
Study Locations (1)
Illinois
- The University of Chicago Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2014-04-28 |
| Est. Completion | 2026-06 |
What the registry record for NCT03182335 still lists
NCT03182335 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 3,130-participant average among 91 other Critical Illness trials with a reported enrollment target (74% lower).
The record links to 3 conditions, with Critical Illness appearing as the primary indexed condition, and to 1 intervention - of which sedation awakening trial is the first listed.
NCT03182335 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03182335 about?
NCT03182335 is a clinical study titled "Vasopressor SAT Study". To assess the impact of daily awakening from sedation on the amount of vasoactive medication required in the ICU. The hypothesis of this proposal is that the amount of vasoactive drug required to maintain an adequate mean arterial blood pressure will be reduced during a daily awakening from sedation...
What is the current status of trial NCT03182335?
This trial is currently active not recruiting. The enrollment target is 800 participants. The study started on 2014-04-28. Estimated completion is 2026-06.
What conditions does trial NCT03182335 study?
This clinical trial studies the following conditions: Critical Illness, Delirium, Low Blood Pressure.
What interventions are being tested in trial NCT03182335?
The interventions under investigation include: sedation awakening trial (OTHER).
Who is sponsoring clinical trial NCT03182335?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03182335 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03182335's enrollment target sits among peer trials
800 22nd of 91 higher than 69 of 91 other Critical Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Critical Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preoperative Fasting vs. Not Fasting in Critically Ill Patients
RECRUITING · NA
-
Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance
RECRUITING
-
Improving Needs Among Older Adults
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
Safety and Feasibility of a Self-Balancing Exoskeleton for Rehabilitation in the Thoracic Surgical Intensive Care Unit: a Pilot Trial
RECRUITING · Phase 1
-
12-hour Time Limited Feeding in Critical Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI